These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18832042)

  • 21. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
    Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
    Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
    Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
    Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Results of intra-arterial administration of PGE1 prostaglandin].
    Ciostek P; Kostewicz W; Górski G
    Wiad Lek; 1994 Oct; 47(19-20):750-2. PubMed ID: 7483622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intra-arterial administration of prostaglandin E1 on rat cremaster muscle microcirculation.
    Natsui H; Yanagi K; Nakayama Y; Ohshima N
    In Vivo; 2001; 15(2):133-8. PubMed ID: 11317517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].
    Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Christopoulos D; Agus G; Bavera P; Mondani P; Ippolito E; Flenda F
    Minerva Cardioangiol; 2002 Dec; 50(6):683-90. PubMed ID: 12473989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty.
    Ray B; Chetter IC; Lee HL; Ettelaie C; McCollum PT
    Br J Surg; 2007 Sep; 94(9):1092-5. PubMed ID: 17497755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of intravenous lipoprostaglandin E1 on neurogenic intermittent claudication.
    Murakami M; Takahashi K; Sekikawa T; Yasuhara K; Yamagata M; Moriya H
    J Spinal Disord; 1997 Dec; 10(6):499-504. PubMed ID: 9438815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of regular physical training in a supervised class and additional intravenous prostaglandin E1 and naftidrofuryl infusion therapy in patients with intermittent claudication--a controlled study.
    Diehm C; Kühn A; Strauss R; Hübsch-Müller C; Kübler W
    Vasa Suppl; 1989; 28():26-30. PubMed ID: 2609241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
    Creutzig A; Caspary L; Radeke U; Specht S; Alexander K
    Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acral skin circulation following intra-arterial infusion of vasodilating substances in patients with intermittent claudication].
    Scheffler A; Rieger H
    Med Klin (Munich); 1990 Jan; 85(1):1-5. PubMed ID: 2314351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Administration of prostaglandin E1 in the treatment of patients with chronic lower limbs critical ischemia with concomitant ischemic heat disease].
    Krotovskiĭ GS; Zudin AM; Kotov AE; Uchkin IG; Zasorina MA; Mosesov AG
    Khirurgiia (Mosk); 2004; (3):31-4. PubMed ID: 15097985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F; Meites G; Rousseau H; Staffin C; Allaert FA; Pelat P
    Ann Radiol (Paris); 1994; 37(3):239-44. PubMed ID: 8092756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of peripheral and cardiopulmonary performance after a short-term exercise program with additive prostaglandin E1.
    Cachovan M; Rogatti W
    Angiology; 2001 Jun; 52(6):381-91. PubMed ID: 11437028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alprostan for management of critical lower limb ischemia].
    Pokrovskiĭ AV; Dan VN; Chupin AV; Kalinin AA
    Angiol Sosud Khir; 2005; 11(1):7-10. PubMed ID: 16034317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
    Belcaro G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):37-43. PubMed ID: 10658443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine.
    Hoh BL; Ogilvy CS
    Neurosurg Clin N Am; 2005 Jul; 16(3):501-16, vi. PubMed ID: 15990041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period].
    Llorente Gutiérrez J; González Fernández MA; Fuentes Irigoyen R; Jiménez Caballero E
    Farm Hosp; 2004; 28(3):188-91. PubMed ID: 15222872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin therapy of peripheral occlusive arterial disease.
    Linhart J
    Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.